Previous experiments demonstrate the ability of the HIF1a inhibitor to both suppress experimental AAA initiation and stabilize existing aneurysms, through mechanisms likely related to impair mural macrophage infiltration and angiogenesis20,32. The gene discussed is HIF1A; the disease is aneurysm.